Remedent, Inc. (REMI)
| Market Cap | 13.49K -98.4% |
| Revenue (ttm) | 50.10K -94.9% |
| Net Income | -330.44K |
| EPS | n/a |
| Shares Out | 19.27M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 30,000 |
| Open | 0.0006 |
| Previous Close | 0.0006 |
| Day's Range | 0.0006 - 0.0007 |
| 52-Week Range | 0.0002 - 0.0551 |
| Beta | -0.42 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About Remedent
Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient’s teeth. Furthe... [Read more]
News
Remedent, Inc. Files Form 15 to Suspend SEC Exchange Act Registration and Applies to Qualify for OTC Markets Alternative Reporting Standard for Pink Sheet Companies
GHENT, Belgium, June 30, 2021 (GLOBE NEWSWIRE) -- Remedent, Inc. (OTC Pink: REMI) (“Remedent” or the “Company”) announced today the voluntary filing of a Form 15 with the United States Securities and ...